Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Clascoterone by Cosmo Pharmaceuticals for Pancreatic Cancer: Likelihood of Approval
Clascoterone is under clinical development by Cosmo Pharmaceuticals and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
Clascoterone by Cosmo Pharmaceuticals for Prostate Cancer: Likelihood of Approval
Clascoterone is under clinical development by Cosmo Pharmaceuticals and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...
Clascoterone by Cosmo Pharmaceuticals for Androgenic Alopecia: Likelihood of Approval
Clascoterone is under clinical development by Cosmo Pharmaceuticals and currently in Phase III for Androgenic Alopecia. According to GlobalData, Phase...